Prediction of new cyanobacterial drug for treating lung cancer

In this study, Tiglicamide A was predicted as the best active cyanobacterial compound derived from Lyngbya confervoides.
Source: Biomedicine and Aging Pathology - Category: Biomedical Science Source Type: research